How AI can help pharma risk managers beat their regulatory nightmares and get the rest they need
from Risk & Insurance
Artificial intelligence is revolutionizing the pharmaceutical industry by empowering companies to dramatically accelerate the development of new drugs while cutting costs by hundreds of millions of dollars. But the growing use of the technology in the industry is also fast creating new risks and updating old ones. By enabling scientists to analyze millions of data points with a few clicks of a mouse, AI technologies such as natural language processing and machine learning have the potential to slash the time it takes for companies to comply with the scientific and regulatory requirements necessary to research, test and market new drugs by several years.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063